Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma

Clinical trial NCT03430687 · WITHDRAWN

Trial details

NCT number: NCT03430687
Sponsor: University of California, San Francisco
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 Stage I Bladder Urothelial Carcinoma AJCC v6 and v7

Start date: 2018-06-01
Primary completion: 2019-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.